The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing beta cells. Dr. Melton is the founder of Harvard’s Stem Cell and Regenerative Biology Laboratory. For over a decade, the UMass DCOE has collaborated with the Melton lab to further characterize these cells’ survival and function in our novel humanized mouse models. We share a common goal of protecting them from autoimmune attack.
Recent Posts
- Interviews of 2025: The Big Issues
- Case Study: Patient Remains Disease Free Five Years After Allogenic CAR T-Cell Therapy
- To Bring Cell Culture into the Future, Consider Microenvironments
- UC Irvine receives $12 million to test novel stem cell therapy for Huntington’s disease
- Novel surgical approach for retinal gene therapy shows promise

